• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人发病的嗜酸性粒细胞性哮喘患者的临床特征

Clinical profile of patients with adult-onset eosinophilic asthma.

作者信息

de Groot Jantina C, Storm Huib, Amelink Marijke, de Nijs Selma B, Eichhorn Edwin, Reitsma Bennie H, Bel Elisabeth H D, Ten Brinke Anneke

机构信息

Dept of Respiratory Medicine, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.

Dept of Clinical Chemistry, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.

出版信息

ERJ Open Res. 2016 May 26;2(2). doi: 10.1183/23120541.00100-2015. eCollection 2016 Apr.

DOI:10.1183/23120541.00100-2015
PMID:27730197
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5005181/
Abstract

Adult-onset eosinophilic asthma is increasingly recognised as a severe and difficult-to-treat subtype of asthma. In clinical practice, early recognition of patients with this asthma subtype is important because it may have treatment implications. Therefore, physicians need to know the distinct characteristics of this asthma phenotype. The objective of the present study was to determine the characteristic profile of patients with adult-onset eosinophilic asthma. 130 patients with adult-onset (>18 years of age) asthma and high blood eosinophil counts (≥0.3×10 L) were compared with 361 adult-onset asthma patients with low (<0.3×10 L) blood eosinophils. Measurements included a series of clinical, functional and imaging parameters. Patients with high blood eosinophils were more often male, had less well controlled asthma and higher exacerbation rates, despite the use of higher doses of inhaled corticosteroids. They had higher levels of total IgE without more sensitisation to common inhaled allergens. In addition, these patients had worse lung function, and more often showed fixed airflow limitation, air trapping, nasal polyposis and abnormalities on sinus computed tomography scanning. Chronic rhinosinusitis, air trapping and male sex were three independent factors associated with blood eosinophilia (adjusted OR 3.8 (95% CI 1.7-8.1), 3.0 (95% CI 1.1-8.1) and 2.4 (95% CI 1.3-4.4), respectively). Patients with adult-onset asthma with elevated blood eosinophils exhibit a distinct profile, which can readily be recognised in clinical practice.

摘要

成人发病的嗜酸性粒细胞性哮喘日益被认为是一种严重且难以治疗的哮喘亚型。在临床实践中,早期识别这种哮喘亚型的患者很重要,因为这可能对治疗有影响。因此,医生需要了解这种哮喘表型的独特特征。本研究的目的是确定成人发病的嗜酸性粒细胞性哮喘患者的特征概况。将130例成人发病(年龄>18岁)且血液嗜酸性粒细胞计数高(≥0.3×10⁹/L)的哮喘患者与361例血液嗜酸性粒细胞计数低(<0.3×10⁹/L)的成人发病哮喘患者进行比较。测量包括一系列临床、功能和影像学参数。血液嗜酸性粒细胞计数高的患者男性居多,哮喘控制较差且加重率较高,尽管使用了更高剂量的吸入性糖皮质激素。他们的总IgE水平较高,但对常见吸入性过敏原的致敏情况并未增加。此外,这些患者的肺功能较差,更常表现为固定性气流受限、气体潴留、鼻息肉以及鼻窦计算机断层扫描异常。慢性鼻窦炎、气体潴留和男性是与血液嗜酸性粒细胞增多相关的三个独立因素(校正比值比分别为3.8(95%可信区间1.7 - 8.1)、3.0(95%可信区间1.1 - 8.1)和2.4(95%可信区间1.3 - 4.4))。血液嗜酸性粒细胞增多的成人发病哮喘患者表现出独特的特征概况,在临床实践中很容易识别。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4610/5005181/c1f802311d53/00100-2015.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4610/5005181/c1f802311d53/00100-2015.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4610/5005181/c1f802311d53/00100-2015.01.jpg

相似文献

1
Clinical profile of patients with adult-onset eosinophilic asthma.成人发病的嗜酸性粒细胞性哮喘患者的临床特征
ERJ Open Res. 2016 May 26;2(2). doi: 10.1183/23120541.00100-2015. eCollection 2016 Apr.
2
Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma.血清 IgE 浓度预测重度嗜酸性粒细胞性哮喘患者恶化风险和 benralizumab 疗效的能力。
Adv Ther. 2020 Feb;37(2):718-729. doi: 10.1007/s12325-019-01191-2. Epub 2019 Dec 14.
3
Last station in the eosinophilic asthma with chronic rhinosinusitis and/or nasal polyposis march: Eosinophilic asthma with radiological findings associated with blood eosinophilia.嗜酸性粒细胞性哮喘合并慢性鼻-鼻窦炎和/或鼻息肉进程的最后一站:伴有与血液嗜酸性粒细胞增多相关的影像学表现的嗜酸性粒细胞性哮喘。
J Asthma. 2019 Feb;56(2):111-117. doi: 10.1080/02770903.2018.1443469. Epub 2018 Apr 3.
4
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.贝那鲁肽治疗重度嗜酸性粒细胞性哮喘患者的疗效发作和对健康相关生活质量的影响、恶化率、肺功能和鼻息肉症状:一项随机、对照、3b 期试验。
Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22.
5
Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.度普利尤单抗对哮喘、伴鼻息肉的慢性鼻-鼻窦炎、特应性皮炎或嗜酸性食管炎患者血液嗜酸性粒细胞计数的影响。
J Allergy Clin Immunol Pract. 2022 Oct;10(10):2695-2709. doi: 10.1016/j.jaip.2022.05.019. Epub 2022 May 28.
6
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
7
Differences in urinary leukotriene E4 levels and distribution of eosinophils between chronic rhinosinusitis patients with aspirin-intolerant and -tolerant asthma.阿司匹林不耐受性哮喘与耐受性哮喘的慢性鼻-鼻窦炎患者之间尿白三烯E4水平及嗜酸性粒细胞分布的差异。
Auris Nasus Larynx. 2016 Jun;43(3):304-8. doi: 10.1016/j.anl.2015.09.016. Epub 2015 Oct 30.
8
Severe adult-onset asthma: A distinct phenotype.严重成人起病哮喘:一种独特的表型。
J Allergy Clin Immunol. 2013 Aug;132(2):336-41. doi: 10.1016/j.jaci.2013.04.052. Epub 2013 Jun 24.
9
Proportion of Severe Asthma Patients Eligible for Mepolizumab Therapy by Age and Age of Onset of Asthma.按年龄和哮喘发病年龄划分的可接受美泊利珠单抗治疗的重度哮喘患者比例。
J Allergy Clin Immunol Pract. 2019 Nov-Dec;7(8):2689-2696.e2. doi: 10.1016/j.jaip.2019.05.053. Epub 2019 Jun 13.
10
Association Between Blood Eosinophils and Neutrophils With Clinical Features in Adult-Onset Asthma.成人起病哮喘患者血液嗜酸性粒细胞和中性粒细胞与临床特征的关系。
J Allergy Clin Immunol Pract. 2023 Mar;11(3):811-821.e5. doi: 10.1016/j.jaip.2022.11.025. Epub 2022 Dec 5.

引用本文的文献

1
Population Pharmacokinetics and Exposure-Response Analysis of Benralizumab in Chinese Adults, Adolescents, and Pediatric Participants with Severe Eosinophilic Asthma.倍利珠单抗在中国患有重度嗜酸性粒细胞性哮喘的成人、青少年和儿童参与者中的群体药代动力学及暴露-反应分析。
Clin Pharmacokinet. 2025 Jun 23. doi: 10.1007/s40262-025-01538-9.
2
A Novel Air Trapping Segment Score Identifies Opposing Effects of Obesity and Eosinophilia on Air Trapping in Asthma.一种新的空气滞留段评分可识别肥胖和嗜酸性粒细胞增多对哮喘中空气滞留的相反影响。
Am J Respir Crit Care Med. 2024 May 15;209(10):1196-1207. doi: 10.1164/rccm.202305-0802OC.
3
Management of eosinophil-associated inflammatory diseases: the importance of a multidisciplinary approach.

本文引用的文献

1
Management of the patient with eosinophilic asthma: a new era begins.嗜酸性粒细胞性哮喘患者的管理:新时代开启。
ERJ Open Res. 2015 Sep 23;1(1). doi: 10.1183/23120541.00024-2015. eCollection 2015 May.
2
Evolving Concepts of Asthma.哮喘的演变概念
Am J Respir Crit Care Med. 2015 Sep 15;192(6):660-8. doi: 10.1164/rccm.201504-0763PP.
3
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials.
嗜酸粒细胞相关性炎症性疾病的管理:多学科方法的重要性。
Front Immunol. 2023 May 17;14:1192284. doi: 10.3389/fimmu.2023.1192284. eCollection 2023.
4
Time-Updated Phenotypic Guidance of Corticosteroids and Antibiotics in COPD: Rationale, Perspective and a Proposed Method.慢性阻塞性肺疾病中皮质类固醇和抗生素的时间更新型表型指导:原理、观点及一种提议方法
Biomedicines. 2023 May 8;11(5):1395. doi: 10.3390/biomedicines11051395.
5
Recent insights in the role of biomarkers in severe asthma management.生物标志物在重度哮喘管理中作用的最新见解。
Front Med (Lausanne). 2022 Sep 26;9:992565. doi: 10.3389/fmed.2022.992565. eCollection 2022.
6
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma.嗜酸性粒细胞炎症:重度哮喘药物治疗的一个有吸引力的靶点。
Biomedicines. 2022 Sep 3;10(9):2181. doi: 10.3390/biomedicines10092181.
7
Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study.PONENTE 研究中贝那利珠单抗实现持久的口服皮质类固醇激素减量后肾上腺功能的恢复。
Eur Respir J. 2022 Dec 22;60(6). doi: 10.1183/13993003.03226-2021. Print 2022 Dec.
8
The emerging roles of eosinophils: Implications for the targeted treatment of eosinophilic-associated inflammatory conditions.嗜酸性粒细胞的新作用:对嗜酸性粒细胞相关炎症性疾病靶向治疗的启示。
Curr Res Immunol. 2022 Mar 21;3:42-53. doi: 10.1016/j.crimmu.2022.03.002. eCollection 2022.
9
Clinical and transcriptomic features of persistent exacerbation-prone severe asthma in U-BIOPRED cohort.U-BIOPRED 队列中持续性加重倾向的严重哮喘的临床和转录组学特征。
Clin Transl Med. 2022 Apr;12(4):e816. doi: 10.1002/ctm2.816.
10
Use of Biologic Therapies in the Treatment of Asthma - A Comparative Real World Data Analysis on Healthcare Resource Utilization and Costs Before and After Therapy Initiation.生物疗法在哮喘治疗中的应用——治疗开始前后医疗资源利用及成本的比较真实世界数据分析
J Asthma Allergy. 2022 Apr 5;15:407-418. doi: 10.2147/JAA.S354062. eCollection 2022.
瑞利珠单抗治疗血嗜酸性粒细胞计数升高的哮喘控制不佳:两项多中心、平行、双盲、随机、安慰剂对照、3 期临床试验结果。
Lancet Respir Med. 2015 May;3(5):355-66. doi: 10.1016/S2213-2600(15)00042-9. Epub 2015 Feb 23.
4
Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care.哮喘表型和生物药物在哮喘和过敏性疾病中的应用:迈向个体化治疗的下一步。
J Allergy Clin Immunol. 2015 Feb;135(2):299-310; quiz 311. doi: 10.1016/j.jaci.2014.12.1871.
5
Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.美泊利珠单抗在嗜酸性粒细胞性哮喘中的口服糖皮质激素节省作用。
N Engl J Med. 2014 Sep 25;371(13):1189-97. doi: 10.1056/NEJMoa1403291. Epub 2014 Sep 8.
6
Mepolizumab treatment in patients with severe eosinophilic asthma.美泊利珠单抗治疗严重嗜酸性粒细胞性哮喘患者。
N Engl J Med. 2014 Sep 25;371(13):1198-207. doi: 10.1056/NEJMoa1403290. Epub 2014 Sep 8.
7
Eosinophils in the spotlight: Eosinophilic airway inflammation in nonallergic asthma.聚焦嗜酸性粒细胞:非过敏性哮喘中的嗜酸性气道炎症
Nat Med. 2013 Aug;19(8):977-9. doi: 10.1038/nm.3300.
8
Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia.贝那鲁肽对痰嗜酸性粒细胞增多的哮喘患者气道嗜酸性粒细胞的影响。
J Allergy Clin Immunol. 2013 Nov;132(5):1086-1096.e5. doi: 10.1016/j.jaci.2013.05.020. Epub 2013 Jul 16.
9
Severe adult-onset asthma: A distinct phenotype.严重成人起病哮喘:一种独特的表型。
J Allergy Clin Immunol. 2013 Aug;132(2):336-41. doi: 10.1016/j.jaci.2013.04.052. Epub 2013 Jun 24.
10
Real life clinical study design supporting the effectiveness of extra-fine inhaled beclomethasone/formoterol at the level of small airways of asthmatics.支持哮喘患者小气道中超细吸入布地奈德/福莫特罗有效性的真实临床研究设计。
Pulm Pharmacol Ther. 2013 Dec;26(6):624-9. doi: 10.1016/j.pupt.2013.06.002. Epub 2013 Jun 14.